Breaking new ground by targeting immune cells to fight metabolic diseases.
Researchers from Monash University found that disabling the enzyme CaMKK2 in macrophages stops inflammation and protects mice from obesity and metabolic issues caused by a high-fat diet. This discovery points to CaMKK2 as a promising target for new treatments against obesity, diabetes, and fatty liver disease.
Leave a comment